The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome.
about
Renin-Angiotensin-aldosterone system in diabetes and hypertensionTwo variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension.Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndromeDiabetes and hypertension: is there a common metabolic pathway?Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines.Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 miceThe Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle.Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomilMineralocorticoid receptor activation in obesity hypertension.Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers.The role of angiotensin receptor blockers in diabetic nephropathy.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance.Regulation of angiotensin II type I receptor (AT1R) protein levels in the obese Zucker rat kidney and urine.Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat.Fructose-rich diet induces gender-specific changes in expression of the renin-angiotensin system in rat heart and upregulates the ACE/AT1R axis in the male rat aorta.Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome
P2860
Q28308222-15A3E490-0655-4772-BE8C-B17E2FFB573EQ34389210-47F1903B-F7CE-42CA-9D1A-9FF2CF0C6AAEQ35085669-384159F5-690D-4AE4-974D-25C73AEACB45Q35850133-0607E096-165C-434A-9305-41A312D51A21Q35857205-6284C3B8-30D9-4686-90C7-936F94D121FEQ36137337-87D4BAF3-9449-426D-A133-881276F25BABQ36854401-54888552-3E80-4CC7-89EF-D1BBCC3FCEB7Q37028323-76711717-01CD-473A-A59A-88AF4EF1A157Q37039767-9087385C-5E2A-4CCA-8D6A-8EB84B410B8AQ37104853-14404D83-4D75-4392-B9C4-108354DD7322Q37167510-F0F4838C-6F5D-4ACE-A49D-3F34E28EF266Q37517178-9735A36F-104F-4F8C-A020-614A33EE2AE7Q37826799-83E17A64-D19C-4E29-920A-60F54A47C22CQ37874892-80150CC2-E4F9-450F-86C9-65EF62ACE798Q38071133-94200101-AF7F-4653-A4F6-0F911A20A11DQ38080812-8F4A96B6-B513-44C1-B5A7-93FE4FF1CED0Q38354900-47114DE2-5B98-499C-BDAB-5EA95A1E150EQ45803207-2C3F345B-9E9A-4F25-9851-3C50D2E8F9D1Q46145184-88B1B06F-796C-4758-A33F-AA210C51A557Q46729820-933BFD84-2282-44AA-9B70-27FB70B470F5Q50904460-78B17F2C-10D1-4B30-809F-98B822ACA5FEQ57490130-277BBA0A-7E6F-4BA2-9F5C-9207A0BF7B2E
P2860
The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of renin-angiotensin ...... the cardiometabolic syndrome.
@en
type
label
The role of renin-angiotensin ...... the cardiometabolic syndrome.
@en
prefLabel
The role of renin-angiotensin ...... the cardiometabolic syndrome.
@en
P2860
P1476
The role of renin-angiotensin ...... the cardiometabolic syndrome.
@en
P2093
Arya M Sharma
Stefan Engeli
P2860
P356
10.1111/J.0197-3118.2006.05422.X
P577
2006-01-01T00:00:00Z